{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:49:55Z","timestamp":1779281395443,"version":"3.51.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>CD103 is characteristically expressed in hairy cell leukemia (HCL), a B-lymphoproliferative disorder highly responsive to treatment with purine analogs. Other CD103+ diseases are rare and do not respond well to the same therapy, including HCL variant (HCLv) and splenic marginal zone B-cell lymphoma (SMZL) variants. We analyzed 215 cases of CD103+ B-lymphoproliferative disorders to further delineate their immunophenotypic features. Flow cytometric analysis revealed that 78.6% of all cases expressed CD25 and CD103, characteristic of classical HCL. Cases analyzed immunohistochemically were also invariably positive for annexin-A1; a subset coexpressed CD10 (33\/169 [19.5%]) or BCL1 (26\/65 [36.9%]). In contrast, 21.4% of cases lacked CD25, a subset of which was analyzed and was invariably negative for annexin-A1, CD10, and BCL1. The CD25\u2013 cases had variable morphologic features ranging from HCLv and SMZL to prolymphocytic leukemia and diffuse large B-cell lymphoma. Clinically, patients with CD25\u2013 disease tended to be older (P = .001), typically had leukocytosis (P = .014), and did not respond well to cladribine or pentostatin. We suggest categorizing CD103+ B-lymphoproliferative disorders into 2 groups. While HCL coexpresses CD25 and annexin-A1, diseases lacking CD25 and annexin-A1 behave clinically differently and can be separated from HCL on diagnosis.<\/jats:p>","DOI":"10.1309\/ajcpl13yduhfkpju","type":"journal-article","created":{"date-parts":[[2009,3,16]],"date-time":"2009-03-16T18:42:48Z","timestamp":1237228968000},"page":"586-595","source":"Crossref","is-referenced-by-count":51,"title":["Immunophenotypic Analysis of CD103+ B-Lymphoproliferative Disorders"],"prefix":"10.1093","volume":"131","author":[{"given":"Henry Y.","family":"Dong","sequence":"first","affiliation":[{"name":"Genzyme Genetics, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Weisberger","sequence":"additional","affiliation":[{"name":"Genzyme Genetics, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zach","family":"Liu","sequence":"additional","affiliation":[{"name":"Genzyme Genetics, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorina","family":"Tugulea","sequence":"additional","affiliation":[{"name":"Genzyme Genetics, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2023011906590761200_b1-1310586","first-page":"1297","article-title":"HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit","volume":"139","author":"Micklem","year":"1991","journal-title":"Am J Pathol"},{"key":"2023011906590761200_b2-1310586","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood.V74.1.320.320","article-title":"Monoclonal antibodies reactive with hairy cell leukemia","volume":"74","author":"Visser","year":"1989","journal-title":"Blood"},{"key":"2023011906590761200_b3-1310586","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1309\/PMQXVY619Q8Y43AR","article-title":"Immunophenotypic variations in hairy cell leukemia","volume":"125","author":"Chen","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b4-1310586","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1073\/pnas.80.14.4522","article-title":"Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia","volume":"80","author":"Korsmeyer","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023011906590761200_b5-1310586","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-0609.1990.tb00447.x","article-title":"Immunophenotype of hairy-cell leukemia","volume":"45","author":"Hassan","year":"1990","journal-title":"Eur J Haematol"},{"key":"2023011906590761200_b6-1310586","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V82.4.1277.1277","article-title":"Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia","volume":"82","author":"Robbins","year":"1993","journal-title":"Blood"},{"key":"2023011906590761200_b7-1310586","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1182\/blood.V83.12.3672.3672","article-title":"Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine","volume":"83","author":"Juliusson","year":"1994","journal-title":"Blood"},{"key":"2023011906590761200_b8-1310586","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","article-title":"The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders","volume":"83","author":"Matutes","year":"1994","journal-title":"Blood"},{"key":"2023011906590761200_b9-1310586","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic lymphoma with villous lymphocytes","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood"},{"key":"2023011906590761200_b10-1310586","first-page":"509","article-title":"Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas","volume":"136","author":"Moller","year":"1990","journal-title":"Am J Pathol"},{"key":"2023011906590761200_b11-1310586","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","article-title":"A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients","volume":"76","author":"Sainati","year":"1990","journal-title":"Blood"},{"key":"2023011906590761200_b12-1310586","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"2023011906590761200_b13-1310586","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"key":"2023011906590761200_b14-1310586","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","article-title":"Leukemic reticuloendotheliosis","volume":"3","author":"Bouroncle","year":"1958","journal-title":"Blood"},{"key":"2023011906590761200_b15-1310586","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.leu.2402784","article-title":"Long-term outcome with pentostatin treatment in hairy cell leukemia patients: a French retrospective study of 238 patients","volume":"17","author":"Maloisel","year":"2003","journal-title":"Leukemia"},{"key":"2023011906590761200_b16-1310586","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2003.05.093","article-title":"Extended follow-up of patients with hairy cell leukemia after treatment with cladribine","volume":"21","author":"Goodman","year":"2003","journal-title":"J Clin Oncol"},{"key":"2023011906590761200_b17-1310586","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience","volume":"106","author":"Chadha","year":"2005","journal-title":"Blood"},{"key":"2023011906590761200_b18-1310586","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnci\/djk030","article-title":"Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study","volume":"99","author":"Hisada","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2023011906590761200_b19-1310586","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM197102182840704","article-title":"Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis","volume":"284","author":"Yam","year":"1971","journal-title":"N Engl J Med"},{"key":"2023011906590761200_b20-1310586","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.pas.0000155152.56736.06","article-title":"High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia","volume":"29","author":"Went","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2023011906590761200_b21-1310586","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ajcp\/98.1.26","article-title":"Hairy cell leukemia: diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44","volume":"98","author":"Hounieu","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b22-1310586","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0145-2126(95)00165-4","article-title":"The value of the monoclonal antibody, DBA44, in the diagnosis of B- lymphoid disorders","volume":"20","author":"Salomon-Nguyen","year":"1996","journal-title":"Leuk Res"},{"key":"2023011906590761200_b23-1310586","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0145-2126(80)90066-1","article-title":"A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia","volume":"4","author":"Cawley","year":"1980","journal-title":"Leuk Res"},{"key":"2023011906590761200_b24-1310586","first-page":"362","article-title":"Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia","volume":"11","author":"Catovsky","year":"1984","journal-title":"Semin Oncol"},{"key":"2023011906590761200_b25-1310586","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajcp\/87.5.576","article-title":"Blastic variant of hairy-cell leukemia","volume":"87","author":"Diez Martin","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b26-1310586","first-page":"54","article-title":"Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases","volume":"75","author":"Zinzani","year":"1990","journal-title":"Haematologica"},{"key":"2023011906590761200_b27-1310586","first-page":"181","article-title":"Predominance of a distinct subtype of hairy cell leukemia in Japan","volume":"7","author":"Machii","year":"1993","journal-title":"Leukemia"},{"key":"2023011906590761200_b28-1310586","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2141.1995.tb05429.x","article-title":"Increased expression of the PRAD-1\/CCND1 gene in hairy cell leukaemia","volume":"91","author":"Bosch","year":"1995","journal-title":"Br J Haematol"},{"key":"2023011906590761200_b29-1310586","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ajcp\/103.6.756","article-title":"Cyclin D1 expression in non-Hodgkin\u2019s lymphomas: detection by immunohistochemistry","volume":"103","author":"Zukerberg","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b30-1310586","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(04)16356-3","article-title":"Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)","volume":"363","author":"Falini","year":"2004","journal-title":"Lancet"},{"key":"2023011906590761200_b31-1310586","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1309\/U98ADVKUC26R2RJA","article-title":"B-cell lymphomas with coexpression of CD5 and CD10","volume":"119","author":"Dong","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b32-1310586","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"key":"2023011906590761200_b33-1310586","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J Exp Med"},{"key":"2023011906590761200_b34-1310586","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.annonc.a010568","article-title":"Involvement of the CCND1 gene in hairy cell leukemia","volume":"7","author":"de Boer","year":"1996","journal-title":"Ann Oncol"},{"key":"2023011906590761200_b35-1310586","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/QVJD31TEG9UJ18BQ","article-title":"Analysis of CD10+ hairy cell leukemia","volume":"120","author":"Jasionowski","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b36-1310586","first-page":"303","article-title":"The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes","volume":"89","author":"Del Giudice","year":"2004","journal-title":"Haematologica"},{"key":"2023011906590761200_b37-1310586","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL): proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"2023011906590761200_b38-1310586","first-page":"1390","article-title":"Immunophenotypic features and configuration of immunoglobulin genes in hairy cell leukemia-Japanese variant","volume":"10","author":"Yamaguchi","year":"1996","journal-title":"Leukemia"},{"key":"2023011906590761200_b39-1310586","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10428199709114177","article-title":"Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine: a report of three cases","volume":"25","author":"Blasinska-Morawiec","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"2023011906590761200_b40-1310586","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1997.15.3.1138","article-title":"Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up","volume":"15","author":"Hoffman","year":"1997","journal-title":"J Clin Oncol"},{"key":"2023011906590761200_b41-1310586","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10428199909145739","article-title":"Treatment of hairy cell leukemia-variant with cladribine","volume":"35","author":"Tetreault","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"2023011906590761200_b42-1310586","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1999.tb01114.x","article-title":"2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland","volume":"62","author":"Robak","year":"1999","journal-title":"Eur J Haematol"},{"key":"2023011906590761200_b43-1310586","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","article-title":"The natural history and clinico-pathological features of the variant form of hairy cell leukemia","volume":"15","author":"Matutes","year":"2001","journal-title":"Leukemia"},{"key":"2023011906590761200_b44-1310586","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/8QYTYQ1CLQMHQ9CL","article-title":"Hairy cell leukemia variant: fact or fiction","volume":"123","author":"Cessna","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2023011906590761200_b45-1310586","first-page":"221","article-title":"Immune phenotype and some enzyme patterns in phorbol ester\u2013induced chronic lymphocytic leukemia cells","volume":"42","author":"Babusikova","year":"1995","journal-title":"Neoplasma"},{"key":"2023011906590761200_b46-1310586","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.1990.tb04349.x","article-title":"Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells","volume":"75","author":"Visser","year":"1990","journal-title":"Br J Haematol"},{"key":"2023011906590761200_b47-1310586","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V27.2.199.199","article-title":"\u201cHairy cells\u201d in blood in lymphoreticular neoplastic disease and \u201cflagellated\u201d cells of normal lymph node","volume":"27","author":"Schrek","year":"1966","journal-title":"Blood"},{"key":"2023011906590761200_b48-1310586","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/10428190500083433","article-title":"Successful treatment of hairy cell leukemia variant with rituximab","volume":"46","author":"Narat","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"2023011906590761200_b49-1310586","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","article-title":"Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia","volume":"345","author":"Kreitman","year":"2001","journal-title":"N Engl J Med"},{"key":"2023011906590761200_b50-1310586","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000115785","article-title":"Effective treatment of a refractory hairy cell leukemia variant with splenic pre-irradiation and alemtuzumab","volume":"119","author":"Sasaki","year":"2008","journal-title":"Acta Haematol"},{"key":"2023011906590761200_b51-1310586","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.10428","article-title":"CD52 expression in hairy cell leukemia","volume":"74","author":"Quigley","year":"2003","journal-title":"Am J Hematol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/131\/4\/586\/48763511\/ajcp_131_4_586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/131\/4\/586\/48763511\/ajcp_131_4_586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:00:25Z","timestamp":1674111625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/131\/4\/586\/1761347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpl13yduhfkpju","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,4,1]]},"published":{"date-parts":[[2009,4,1]]}}}